Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
140.83
Dollar change
-8.39
Percentage change
-5.62
%
IndexS&P 500 P/E14.21 EPS (ttm)9.91 Insider Own5.42% Shs Outstand68.55M Perf Week28.80%
Market Cap9.94B Forward P/E8.75 EPS next Y16.09 Insider Trans-35.00% Shs Float66.78M Perf Month26.86%
Enterprise Value23.84B PEG0.42 EPS next Q2.34 Inst Own92.81% Short Float10.40% Perf Quarter16.23%
Income746.80M P/S0.73 EPS this Y29.14% Inst Trans-1.90% Short Ratio6.66 Perf Half Y10.29%
Sales13.64B P/B- EPS next Y15.55% ROA4.07% Short Interest6.94M Perf YTD23.96%
Book/sh-9.50 P/C12.71 EPS next 5Y20.99% ROE635.30% 52W High178.38 -21.05% Perf Year-20.37%
Cash/sh11.08 P/FCF7.58 EPS past 3/5Y19.91% 9.03% ROIC6.39% 52W Low101.00 39.44% Perf 3Y66.05%
Dividend Est.1.67 (1.18%) EV/EBITDA8.75 Sales past 3/5Y5.53% 3.39% Gross Margin27.00% Volatility7.37% 3.92% Perf 5Y18.53%
Dividend TTM- EV/Sales1.75 EPS Y/Y TTM-8.23% Oper. Margin14.74% ATR (14)5.94 Perf 10Y109.82%
Dividend Ex-Date- Quick Ratio1.24 Sales Y/Y TTM6.46% Profit Margin5.47% RSI (14)71.87 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio1.29 EPS Q/Q6.38% SMA2023.45% Beta0.90 Target Price151.00
Payout0.00% Debt/Eq- Sales Q/Q9.87% SMA5021.76% Rel Volume2.16 Prev Close149.22
Employees76000 LT Debt/Eq- EarningsFeb 02 AMC SMA2008.36% Avg Volume1.04M Price140.83
IPOOct 31, 1995 Option/ShortYes / Yes EPS/Sales Surpr.4.88% 3.24% Trades Volume2,254,829 Change-5.62%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Feb-05-26 09:40AM
09:40AM
Feb-04-26 07:55PM
02:54PM
10:59AM
06:03PM Loading…
Feb-03-26 06:03PM
04:26PM
01:18PM
12:38PM
12:25PM
11:45AM
11:16AM
11:14AM
10:23AM
09:59AM
09:40AM Loading…
09:40AM
08:10AM
05:54AM
12:01AM
Feb-02-26 09:55PM
08:40PM
06:38PM
05:20PM
04:20PM
04:05PM
03:00PM
Jan-31-26 10:01PM
Jan-30-26 11:56AM
Jan-29-26 11:34PM
Jan-27-26 06:00PM
06:15PM Loading…
Jan-21-26 06:15PM
10:00AM
Jan-19-26 12:31PM
Jan-16-26 01:56PM
04:25AM
Jan-15-26 10:34AM
Jan-14-26 11:50AM
Jan-13-26 06:00PM
Jan-07-26 06:00PM
06:00AM
Jan-02-26 09:32AM
Dec-29-25 08:53AM
01:30AM
Dec-23-25 09:02AM
Dec-22-25 06:00PM
09:14AM
Dec-19-25 09:13AM
Dec-18-25 09:07AM
Dec-15-25 09:05AM
Dec-11-25 08:00AM
Nov-28-25 11:30AM
Nov-24-25 11:49AM
Nov-14-25 04:53PM
04:16PM
Nov-13-25 10:31PM
Nov-12-25 01:11PM
Nov-10-25 06:41AM
Nov-05-25 12:38AM
Nov-04-25 08:00AM
Nov-02-25 01:07PM
Oct-30-25 07:39PM
01:59PM
01:35AM
Oct-29-25 05:25PM
05:25PM
04:05PM
Oct-28-25 11:27AM
11:27AM
Oct-27-25 11:07PM
Oct-26-25 04:23PM
Oct-20-25 06:00PM
08:00AM
Oct-17-25 09:06AM
Oct-14-25 06:15PM
Oct-13-25 02:00PM
Oct-12-25 01:01PM
Oct-08-25 11:31PM
06:00PM
Oct-06-25 06:15PM
Oct-03-25 09:45AM
Oct-02-25 09:40AM
Sep-30-25 06:15PM
Sep-25-25 10:21AM
Sep-24-25 01:11PM
Sep-23-25 06:00PM
09:56AM
Sep-22-25 09:40AM
Sep-17-25 06:00PM
09:45AM
Sep-16-25 09:40AM
Sep-13-25 09:45AM
Sep-10-25 06:00PM
06:00PM
12:05AM
Sep-02-25 04:26PM
Sep-01-25 09:45AM
Aug-29-25 09:40AM
12:33AM
Aug-27-25 09:53AM
08:00AM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERKSHIRE HATHAWAY INC10% OwnerJan 29 '26Sale120.561,658,480199,939,88130,100,585Feb 02 05:30 PM
HEARTY JAMES OChief Compliance OfficerDec 04 '25Option Exercise108.935,875639,96431,913Dec 05 04:35 PM
BERKSHIRE HATHAWAY INC10% OwnerOct 27 '25Sale135.36401,51454,347,24931,759,065Oct 29 06:09 PM
BERKSHIRE HATHAWAY INC10% OwnerJul 31 '25Sale140.611,635,962230,024,76432,160,579Aug 04 09:00 PM
HEARTY JAMES OChief Compliance OfficerJul 23 '25Sale150.002,351352,65026,038Jul 24 08:34 PM
HEARTY JAMES OOfficerJul 23 '25Proposed Sale150.002,351352,650Jul 23 04:05 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 27 '25Sale139.45103,27414,401,48333,796,541May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 23 '25Sale137.8164,0668,828,93333,899,815May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 22 '25Sale138.9832,6604,538,98333,963,881May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 08 '25Sale147.111,145,938168,576,64733,996,541May 12 04:05 PM
HEARTY JAMES OChief Compliance OfficerMar 03 '25Option Exercise75.954,609350,05428,669Mar 14 07:55 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 14 '25Sale154.94500,00077,471,99635,392,479Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 19 '25Sale154.09129,93820,022,51735,142,479Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 18 '25Sale154.60120,06218,561,10335,272,417Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 11 '25Sale156.01203,09131,684,43035,892,479Feb 13 07:50 PM
Last Close
Feb 06  •  04:00PM ET
292.05
Dollar change
+7.52
Percentage change
2.64
%
CI Cigna Group daily Stock Chart
IndexS&P 500 P/E13.16 EPS (ttm)22.19 Insider Own1.62% Shs Outstand263.46M Perf Week6.54%
Market Cap78.01B Forward P/E8.75 EPS next Y33.36 Insider Trans-0.68% Shs Float262.80M Perf Month4.63%
Enterprise Value- PEG1.16 EPS next Q7.36 Inst Own90.77% Short Float1.81% Perf Quarter12.51%
Income5.96B P/S0.36 EPS this Y1.41% Inst Trans1.31% Short Ratio2.65 Perf Half Y7.77%
Sales216.66B P/B1.84 EPS next Y10.25% ROA4.01% Short Interest4.76M Perf YTD6.11%
Book/sh158.33 P/C- EPS next 5Y7.54% ROE14.40% 52W High350.00 -16.56% Perf Year-0.43%
Cash/sh- P/FCF10.49 EPS past 3/5Y1.18% -0.69% ROIC8.19% 52W Low239.51 21.94% Perf 3Y-6.78%
Dividend Est.6.26 (2.14%) EV/EBITDA- Sales past 3/5Y-31.46% -18.43% Gross Margin- Volatility3.68% 2.79% Perf 5Y34.71%
Dividend TTM6.04 (2.07%) EV/Sales- EPS Y/Y TTM113.48% Oper. Margin4.42% ATR (14)7.83 Perf 10Y118.60%
Dividend Ex-DateMar 05, 2026 Quick Ratio- Sales Y/Y TTM-11.34% Profit Margin2.75% RSI (14)63.84 Recom1.50
Dividend Gr. 3/5Y10.47% 172.77% Current Ratio0.83 EPS Q/Q-9.40% SMA205.87% Beta0.27 Target Price331.64
Payout27.23% Debt/Eq0.82 Sales Q/Q-78.45% SMA506.19% Rel Volume1.59 Prev Close284.53
Employees73500 LT Debt/Eq0.74 EarningsFeb 05 BMO SMA200-0.80% Avg Volume1.80M Price292.05
IPOMay 16, 1979 Option/ShortYes / Yes EPS/Sales Surpr.2.53% 3.11% Trades Volume2,865,751 Change2.64%
Date Action Analyst Rating Change Price Target Change
Oct-14-25Initiated Goldman Buy $370
Feb-06-25Downgrade Bernstein Outperform → Mkt Perform $323
Jun-26-24Initiated Piper Sandler Overweight $400
May-30-24Initiated Robert W. Baird Outperform $388
Mar-06-24Initiated Barclays Overweight $393
Feb-05-24Upgrade RBC Capital Mkts Sector Perform → Outperform $327 → $354
Feb-05-24Upgrade Cantor Fitzgerald Neutral → Overweight $334 → $372
Feb-01-24Upgrade Deutsche Bank Hold → Buy $355 → $370
Jan-04-24Upgrade Bernstein Mkt Perform → Outperform $330 → $372
Dec-11-23Upgrade Jefferies Hold → Buy $335 → $341
Feb-06-26 01:32PM
01:23PM
09:50AM
05:29AM
12:33AM
07:56PM Loading…
Feb-05-26 07:56PM
04:04PM
12:56PM
12:49PM
11:52AM
11:47AM
10:32AM
09:30AM
08:01AM
07:10AM
06:43AM Loading…
06:43AM
06:15AM
06:15AM
06:13AM
06:00AM
04:59AM
04:18AM
Feb-04-26 07:00PM
07:28AM
06:46AM
Feb-03-26 10:05PM
08:17PM
11:00AM
03:08AM
Feb-02-26 12:27PM
10:47AM Loading…
10:47AM
09:15AM
08:42AM
08:29AM
Feb-01-26 07:47AM
Jan-30-26 10:27AM
Jan-29-26 02:19AM
Jan-27-26 04:44PM
04:44PM
04:41PM
11:42AM
Jan-26-26 10:16PM
05:34PM
05:34PM
Jan-25-26 12:39PM
04:46AM
Jan-24-26 09:00AM
Jan-23-26 05:25PM
04:42PM
02:36PM
01:31PM
03:36AM
Jan-22-26 11:31AM
09:16AM
06:58AM
Jan-21-26 11:21AM
Jan-20-26 10:12AM
Jan-19-26 07:38AM
Jan-18-26 12:55AM
Jan-16-26 02:30AM
Jan-15-26 04:16PM
12:04PM
09:00AM
08:00AM
Jan-14-26 12:53PM
Jan-13-26 06:00AM
Jan-07-26 10:01AM
08:20AM
06:00AM
Jan-06-26 10:48AM
Jan-05-26 03:53AM
Jan-02-26 11:12AM
Dec-19-25 04:58PM
04:20PM
08:45AM
Dec-18-25 11:05PM
05:30AM
Dec-12-25 05:30AM
Dec-11-25 01:08PM
Dec-10-25 10:33AM
09:00AM
Dec-09-25 03:25PM
Dec-08-25 12:10PM
Dec-04-25 01:41PM
Dec-03-25 09:06AM
Nov-28-25 07:08AM
05:47AM
02:19AM
Nov-23-25 10:26AM
Nov-21-25 06:00PM
Nov-20-25 08:10AM
Nov-16-25 10:33PM
Nov-12-25 11:32PM
02:05PM
06:00AM
04:36AM
02:30AM
Nov-11-25 08:08AM
Nov-10-25 09:52AM
09:07AM
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Granger ElderFormer DirectorFeb 06 '26Proposed Sale293.326,1091,791,895Feb 06 02:05 PM
Cordani DavidChairman & CEONov 03 '25Buy241.884,134999,916157,935Nov 03 02:47 PM
Evanko Brian CSee RemarksOct 03 '25Option Exercise139.225,368747,33356,550Oct 07 05:22 PM
Evanko Brian CSee RemarksOct 06 '25Option Exercise139.22901125,43752,083Oct 07 05:22 PM
Evanko Brian CSee RemarksOct 03 '25Sale300.005,3681,610,40051,182Oct 07 05:22 PM
Evanko Brian COfficerOct 03 '25Proposed Sale300.005,3681,610,400Oct 03 11:35 AM
Jones Nicole SSee RemarksAug 15 '25Option Exercise190.8324,7534,723,68254,174Aug 19 05:15 PM
Jones Nicole SSee RemarksAug 18 '25Option Exercise190.352,677509,55628,325Aug 19 05:15 PM
Jones Nicole SSee RemarksAug 15 '25Sale300.0028,5268,557,80025,648Aug 19 05:15 PM
Jones Nicole SOfficerAug 15 '25Proposed Sale300.0028,5268,557,800Aug 15 03:54 PM
Eder Noelle KFormer OfficerAug 12 '25Proposed Sale275.0635,7119,822,668Aug 12 10:51 AM
Palmer Eric PFormer OfficerMay 09 '25Proposed Sale335.08610204,399May 09 04:27 PM
Palmer Eric PFormer OfficerMay 08 '25Proposed Sale335.6114,9855,029,097May 08 04:11 PM
Palmer Eric PFormer OfficerMay 07 '25Proposed Sale335.0387,17129,204,506May 07 05:13 PM
Palmer Eric PFormer OfficerMay 06 '25Proposed Sale334.7435,97712,042,965May 06 04:47 PM
Palmer Eric PFormer OfficerMay 05 '25Proposed Sale335.035,6001,876,147May 05 04:44 PM
Triplett Michael WFormer OfficerMar 28 '25Proposed Sale327.01812265,532Mar 28 12:57 PM
Granger ElderDirectorMar 14 '25Option Exercise151.482,376359,9137,847Mar 17 05:06 PM
Granger ElderDirectorMar 14 '25Sale310.352,376737,3925,471Mar 17 05:06 PM
Granger ElderDirectorMar 14 '25Proposed Sale310.352,376737,392Mar 14 09:44 AM
Eder Noelle KSee RemarksMar 07 '25Sale320.009,9443,182,08013,406Mar 11 05:11 PM
Eder Noelle KOfficerMar 07 '25Proposed Sale320.009,9443,182,080Mar 07 01:09 PM
Triplett Michael WFormer OfficerMar 05 '25Proposed Sale309.594,9661,537,448Mar 05 05:00 PM
Cordani DavidChairman & CEOMar 03 '25Sale308.1226,5278,173,499127,767Mar 04 07:52 PM
Jones Nicole SSee RemarksMar 03 '25Sale308.124,9041,511,02029,421Mar 04 07:52 PM
Jones Nicole SOfficerMar 03 '25Proposed Sale308.124,9041,511,020Mar 03 09:58 AM
Cordani DavidOfficerMar 03 '25Proposed Sale308.1226,5278,173,499Mar 03 09:37 AM